Evidence map›Paper›PMID 40469089›Full record

ArticleFrontiers in pediatrics2025

Impaired airway epithelial miR-155/BACH1/NRF2 axis and hypoxia gene expression during RSV infection in children with down syndrome.

Allison Welham, Elizabeth Chorvinsky, Surajit Bhattacharya, Kyle Salka, Betelehem Solomon Bera, Woudasie Admasu, Maria C Straker, Maria J Gutierrez, Jyoti K Jaiswal, Gustavo Nino

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Allison Welham *Division of Pediatric Pulmonary and Sleep Medicine, Children's National Hospital, Washington, DC, United States.
Elizabeth Chorvinsky *Division of Pediatric Pulmonary and Sleep Medicine, Children's National Hospital, Washington, DC, United States.
Surajit BhattacharyaDivision of Pediatric Pulmonary and Sleep Medicine, Children's National Hospital, Washington, DC, United States.
Kyle SalkaJacobs School of Medicine and Biomedical Sciences, University of Buffalo, Buffalo, NY, United States.
Betelehem Solomon BeraDivision of Pediatric Pulmonary and Sleep Medicine, Children's National Hospital, Washington, DC, United States.
Woudasie AdmasuDivision of Pediatric Pulmonary and Sleep Medicine, Children's National Hospital, Washington, DC, United States.
Maria C StrakerDivision of Pediatric Pulmonary and Sleep Medicine, Children's National Hospital, Washington, DC, United States.
Maria J GutierrezDivision of Pediatric Allergy, Immunology and Rheumatology, Johns Hopkins University, Baltimore, MD, United States.
Jyoti K JaiswalCenter for Genetic Medicine Research, Children's National Research Institute, Washington, DC, United States.
Gustavo NinoDivision of Pediatric Pulmonary and Sleep Medicine, Children's National Hospital, Washington, DC, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Children with Down Syndrome (DS) are at high risk for severe respiratory syncytial virus (RSV) infections. DS is associated with impaired cellular responses to oxidative stress and hypoxia; however, these abnormalities have not been explored in trisomy 21 (TS21) airway epithelial cells (AECs) during RSV infection. Understanding these defects is key to identifying factors contributing to severe RSV infections in this high-risk group. Methods: AECs from children with and without DS were analyzed at baseline and after RSV infection to assess NRF2-induced protective genes against oxidative stress and hypoxia, including the enzyme heme oxygenase 1 (HO-1). To investigate DS-specific defects, we focused on miR-155 and BACH1, which regulate NRF2 signaling and HO-1 expression, and are both encoded on chromosome 21. RNA-seq analyses were performed to examine genome-wide hypoxia-related gene responses in control and TS21 AECs at baseline and after RSV infection. Results: Our findings show that miR-155 inhibits BACH1, leading to increased NRF2-driven HO-1 expression in euploid AECs. In contrast, TS21 AECs from children with DS exhibited impaired HO-1 induction following miR-155 treatment. This was attributed to reduced transcription of the HMOX1 gene, which encodes HO-1, along with global downregulation of hypoxia response genes in DS at baseline and after RSV infection in TS21 AECs. Conclusions: Severe RSV infections in children with DS may be linked to intrinsic defects in AEC responses to hypoxia, including NRF2-driven cytoprotective enzymes like HO-1. These findings offer new mechanistic insights into RSV pathophysiology and potential therapeutic targets in children with DS.

Indexed as

airway epitheliahypoxiamiR-155RSV (respiratory syncytial virus)trisomy 21 (Down syndrome)

Identifiers

PMID40469089
PMCPMC12134073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.